Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial von Motzer, Robert J, Dr, Hutson, Thomas E, DO, Glen, Hilary, MD, Michaelson, M Dror, MD, Molina, Ana, MD, Eisen, Timothy, Prof, Jassem, Jacek, Prof, Zolnierek, Jakub, MD, Maroto, Jose Pablo, MD, Mellado, Begoña, MD, Melichar, Bohuslav, Prof, Tomasek, Jiri, MD, Kremer, Alton, MD, Kim, Han-Joo, PhD, Wood, Karen, PhD, Dutcus, Corina, MD, Larkin, James, FRCP

Volltext

Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis von Choueiri, Toni K., Bauer, Todd M., Papadopoulos, Kyriakos P., Plimack, Elizabeth R., Merchan, Jaime R., McDermott, David F., Michaelson, M. Dror, Appleman, Leonard J., Thamake, Sanjay, Perini, Rodolfo F., Zojwalla, Naseem J., Jonasch, Eric

Volltext

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial von Motzer, Robert J, Dr, Escudier, Bernard, MD, Tomczak, Piotr, MD, Hutson, Thomas E, DO, Michaelson, M Dror, MD, Negrier, Sylvie, Prof, Oudard, Stephane, Prof, Gore, Martin E, Prof, Tarazi, Jamal, MD, Hariharan, Subramanian, MD, Chen, Connie, PharmD, Rosbrook, Brad, MS, Kim, Sinil, MD, Rini, Brian I, MD

Volltext

Sequential mechanism in H3+ formation dynamics on the ethanol dication von Gope, Krishnendu, Bittner, Dror M, Strasser, Daniel

Volltext

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial von Rini, Brian I, Dr, Escudier, Bernard, MD, Tomczak, Piotr, MD, Kaprin, Andrey, Prof, Szczylik, Cezary, MD, Hutson, Thomas E, DO, Michaelson, M Dror, MD, Gorbunova, Vera A, Prof, Gore, Martin E, Prof, Rusakov, Igor G, Prof, Negrier, Sylvie, Prof, Ou, Yen-Chuan, Prof, Castellano, Daniel, MD, Lim, Ho Yeong, Prof, Uemura, Hirotsugu, Prof, Tarazi, Jamal, MD, Cella, David, PhD, Chen, Connie, PharmD, Rosbrook, Brad, MS, Kim, Sinil, MD, Motzer, Robert J, MD

Volltext

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free surv... von Choueiri, Toni K., Hessel, Colin, Halabi, Susan, Sanford, Ben, Michaelson, M. Dror, Hahn, Olwen, Walsh, Meghara, Olencki, Thomas, Picus, Joel, Small, Eric J., Dakhil, Shaker, Feldman, Darren R., Mangeshkar, Milan, Scheffold, Christian, George, Daniel, Morris, Michael J.

Volltext

Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study von Choueiri, Toni K, McDermott, David F, Merchan, Jaime, Bauer, Todd M, Figlin, Robert, Heath, Elisabeth I, Michaelson, M Dror, Arrowsmith, Edward, D'Souza, Anishka, Zhao, Song, Roy, Ananya, Perini, Rodolfo, Vickery, Donna, Tykodi, Scott S

Volltext

Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis von Zlotta, Alexandre R, Ballas, Leslie K, Niemierko, Andrzej, Lajkosz, Katherine, Kuk, Cynthia, Miranda, Gus, Drumm, Michael, Mari, Andrea, Thio, Ethan, Fleshner, Neil E, Kulkarni, Girish S, Jewett, Michael A S, Bristow, Robert G, Catton, Charles, Berlin, Alejandro, Sridhar, Srikala S, Schuckman, Anne, Feldman, Adam S, Wszolek, Matthew, Dahl, Douglas M, Lee, Richard J, Saylor, Philip J, Michaelson, M Dror, Miyamoto, David T, Zietman, Anthony, Shipley, William, Chung, Peter, Daneshmand, Siamak, Efstathiou, Jason A

Volltext

Sequential mechanism in H 3 + formation dynamics on the ethanol dication von Gope, Krishnendu, Bittner, Dror M, Strasser, Daniel

Volltext

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma von Motzer, Robert J, Hutson, Thomas E, Tomczak, Piotr, Michaelson, M. Dror, Bukowski, Ronald M, Rixe, Olivier, Oudard, Stéphane, Negrier, Sylvie, Szczylik, Cezary, Kim, Sindy T, Chen, Isan, Bycott, Paul W, Baum, Charles M, Figlin, Robert A

Volltext

Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes von Nuzzo, Pier Vitale, Berchuck, Jacob E., Korthauer, Keegan, Spisak, Sandor, Nassar, Amin H., Abou Alaiwi, Sarah, Chakravarthy, Ankur, Shen, Shu Yi, Bakouny, Ziad, Boccardo, Francesco, Steinharter, John, Bouchard, Gabrielle, Curran, Catherine R., Pan, Wenting, Baca, Sylvan C., Seo, Ji-Heui, Lee, Gwo-Shu Mary, Michaelson, M. Dror, Chang, Steven L., Waikar, Sushrut S., Sonpavde, Guru, Irizarry, Rafael A., Pomerantz, Mark, De Carvalho, Daniel D., Choueiri, Toni K., Freedman, Matthew L.

Volltext

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial von Choueiri, Toni K, Halabi, Susan, Sanford, Ben L, Hahn, Olwen, Michaelson, M Dror, Walsh, Meghara K, Feldman, Darren R, Olencki, Thomas, Picus, Joel, Small, Eric J, Dakhil, Shaker, George, Daniel J, Morris, Michael J

Volltext

Treatment sequences for advanced renal cell carcinoma: A health economic assessment von Deniz, Baris, Ambavane, Apoorva, Yang, Shuo, Altincatal, Arman, Doan, Justin, Rao, Sumati, Michaelson, M Dror

Volltext

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins von Deprimo, Samuel E, Bello, Carlo L, Smeraglia, John, Baum, Charles M, Spinella, Dominic, Rini, Brian I, Michaelson, M Dror, Motzer, Robert J

Volltext

Antitumor Activity and Biomarker Analysis of Sunitinib in Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma von RINI, Brian I, DROR MICHAELSON, M, KIM, Sindy T, CHEN, Isan, GEORGE, Daniel J, ROSENBERG, Jonathan E, BUKOWSKI, Ronald M, SOSMAN, Jeffrey A, STADLER, Walter M, HUTSON, Thomas E, MARGOLIN, Kim, HARMON, Charles S, DEPRIMO, Samuel E

Volltext

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma von MOTZER, Robert J, HUTSON, Thomas E, GARCIA-DEL-MURO, Xavier, SOSMAN, Jeffrey A, SOLSKA, Ewa, WILDING, George, THOMPSON, John A, KIM, Sindy T, CHEN, Isan, XIN HUANG, FIGLIN, Robert A, TOMCZAK, Piotr, MICHAELSON, M. Dror, BUKOWSKI, Ronald M, OUDARD, Stéphane, NEGRIER, Sylvie, SZCZYLIK, Cezary, PILI, Roberto, BJARNASON, Georg A

Volltext

Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer von DROR MICHAELSON, M, OUDARD, Stephane, LAESTADIUS, Fredrik, ULLEN, Anders, BAHL, Amit, CASTELLANO, Daniel, GSCHWEND, Juergen, MAURINA, Tristan, CHOW MANEVAL, Edna, WANG, Shaw-Ling, LECHUGA, Maria Jose, PAOLINI, Jolanda, OU, Yen-Chuan, ISAN CHEN, SENGELØV, Lisa, SAAD, Fred, HOUEDE, Nadine, OSTLER, Peter, STENZL, Arnulf, DAUGAARD, Gedske, JONES, Robert

Volltext

Time-resolved dissociative ionization and double photoionization of CO2 von Bittner, Dror M., Gope, Krishnendu, Strasser, Daniel

Volltext

Sequential and concerted C–C and C–O bond dissociation in the Coulomb explosion of 2-propanol von Bittner, Dror M., Gope, Krishnendu, Livshits, Ester, Baer, Roi, Strasser, Daniel

Volltext

Absence of Triplets in Single-Photon Double Ionization of Methanol von Gope, Krishnendu, Livshits, Ester, Bittner, Dror M, Baer, Roi, Strasser, Daniel

Volltext